Nadège Pelletier

2023

In 2023, Nadège Pelletier earned a total compensation of $1.7M as Chief Scientific Officer at Barinthus Biotherapeutics plc..

Compensation breakdown

Non-Equity Incentive Plan$140,867
Option Awards$1,114,349
Salary$382,791
Other$34,992
Total$1,672,999

Pelletier received $1.1M in option awards, accounting for 67% of the total pay in 2023.

Pelletier also received $140.9K in non-equity incentive plan, $382.8K in salary and $35K in other compensation.

Rankings

In 2023, Nadège Pelletier's compensation ranked 678th out of 2,978 executives tracked by ExecPay. In other words, Pelletier earned more than 77.2% of executives.

ClassificationRankingPercentile
All
678
out of 2,978
77th
Division
Manufacturing
383
out of 1,637
77th
Major group
Chemicals And Allied Products
261
out of 906
71st
Industry group
Drugs
257
out of 869
70th
Industry
Pharmaceutical Preparations
164
out of 627
74th
Source: SEC filing on March 22, 2024.

Pelletier's colleagues

We found two more compensation records of executives who worked with Nadège Pelletier at Barinthus Biotherapeutics plc. in 2023.

2023

William Enright

Barinthus Biotherapeutics plc.

Chief Executive Officer

2023

Graham Griffiths

Barinthus Biotherapeutics plc.

Chief Business Officer

News

In-depth

You may also like